Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Glycopyrrolate and Indacaterol bulk supplier for pharma manufacturers

Glycopyrrolate And Indacaterol Suppliers & Bulk Manufacturers

Available Forms: Subcutaneous injection

Available Strengths: 27.5 mcg + 15.6 mcg or 85 mcg + 43 mcg

Reference Brands: Utibron Neohaler(US), Ultibro Breezhaler(EU)

Category: Respiratory Disorder

Glycopyrrolate and indacaterol is a dual bronchodilator used for COPD maintenance treatment. It combines a LAMA and a LABA to improve breathing and reduce symptoms. Available as a dry powder inhaler under brands like Ultibro Breezhaler, it is taken once daily for long-term lung function support.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Glycopyrrolate and indacaterol is a fixed-dose combination used in the maintenance treatment of chronic obstructive pulmonary disease (COPD). This dual bronchodilator combines a long-acting muscarinic antagonist (LAMA) with a long-acting beta-agonist (LABA) to improve lung function and reduce COPD symptoms. Available under brand names like Ultibro Breezhaler in the EU and previously Utibron Neohaler in the US, it is delivered via dry powder inhaler (DPI) for once-daily or twice-daily use. The combination enhances airway relaxation, reduces breathlessness, and supports better respiratory control. It is not intended for asthma or acute bronchospasm relief.

Glycopyrrolate And Indacaterol — third party manufacturing & bulk supply

Glycopyrrolate And Indacaterol is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Glycopyrrolate And Indacaterol is supplied as Subcutaneous injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Glycopyrrolate And Indacaterol listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Glycopyrrolate And Indacaterol →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Glycopyrrolate and Indacaterol is listed as Subcutaneous injection in 27.5 mcg + 15.6 mcg or 85 mcg + 43 mcg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Glycopyrrolate and Indacaterol is referenced against Utibron Neohaler(US), Ultibro Breezhaler(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Glycopyrrolate and Indacaterol is catalogued under Respiratory Disorder on PharmaTradz. Related products within the same category are listed at the foot of this page.

Submit an RFQ stating your destination market, required quantity and whether you need stock supply, third party manufacturing or dossier licensing. Matched suppliers respond with pricing, MOQ and lead times.

Related Products

Salmeterol Xinafoate

Strength:
25 µg, 50 µg

Form: Inhalation

Reference Brands: Serevent (USA/LATAM/EU)

View Details
Formoterol Fumarate

Strength:
12 µg

Form: Inhalation

Reference Brands: Foradil (USA/LATAM), Oxis (India)

View Details
Ethionamide

Strength:
250 mg

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details
Olodaterol

Strength:
2.5 mcg

Form: Inhalation solution

Reference Brands: Striverdi Respimat (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.